Sarah Bly is Director of Regulatory Science, Strategy and Innovation at Worldwide Clinical Trials. Based in the UK with over 19 years’ experience in the pharmaceutical industry. Sarah is a lead in providing high level strategic regulatory strategies, risk assessments and solutions including driving health equity strategies. Sarah is also an active volunteer and stakeholder for initiatives such as EU-X-CT which aims to improve cross-border access to clinical trials for patients in the EU.
